Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12582710 | Single-chain coronavirus viral membrane protein complexes | 🖼🧊📄§ | 2026-03-24 | 2041-08-27 | 0 | 31 |
| 12582711 | RNA-based adjuvant to enhance the immune response to vaccines and therapeutics | 🖼🧊📄§ | 2026-03-24 | 2042-08-18 | 0 | 31 |
| 12582712 | Method of making anti-pro/latent myostatin antibodies | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12582709 | Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways | 🖼🧊📄§ | 2026-03-24 | 2041-07-01 | 0 | 31 |
| 12582708 | Recombinant influenza viruses comprising truncated NS1 fusion proteins | 🖼🧊📄§ | 2026-03-24 | 2040-02-10 | 0 | 31 |
| 12582700 | Activin receptor type IIA variants and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2045-06-05 | 0 | 31 |
| 12582703 | Blood substitutes comprising hemoglobin and methods of making | 🖼🧊📄§ | 2026-03-24 | 2042-11-08 | 0 | 31 |
| 12582704 | Food composition for improving behavioral and motor function containing aldehyde dehydrogenase for reducing aldehydes produced by oxidation of alcohol | 🖼🧊📄§ | 2026-03-24 | 2044-08-09 | 0 | 31 |
| 12582699 | Compositions and methods for enhanced lymphocyte-mediated immunotherapy | 🖼🧊📄§ | 2026-03-24 | 2040-02-12 | 0 | 31 |
| 12582695 | Compositions and methods for treating glioma | 🖼🧊📄§ | 2026-03-24 | 2039-11-27 | 0 | 31 |
| 12582693 | Glutathione trisulfide (GSSSG) in neuroprotection | 🖼🧊📄§ | 2026-03-24 | 2041-05-11 | 0 | 31 |
| 12582687 | Composition based on Crocus sativus and Cannabis sativa | 🖼🧊📄§ | 2026-03-24 | 2042-08-04 | 0 | 31 |
| 12582686 | Manufacturing method for composition promoting recovery of bone fracture | 🖼🧊📄§ | 2026-03-24 | 2043-12-20 | 0 | 31 |
| 12582688 | Compositions for the treatment of hypopigmentation | 🖼🧊📄§ | 2026-03-24 | 2042-06-28 | 0 | 31 |
| 12582689 | Use of terpenoids in the treatment or prevention of fibrotic diseases | 🖼🧊📄§ | 2026-03-24 | 2041-05-19 | 0 | 31 |
| 12582679 | Compositions and methods for the treatment of allergy | 🖼🧊📄§ | 2026-03-24 | 2041-04-19 | 0 | 31 |
| 12582682 | Probiotic compositions for the treatment of acne | 🖼🧊📄§ | 2026-03-24 | 2041-09-14 | 0 | 31 |
| 12582681 | Fermented milk product for administration in canids such as dogs, and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2040-09-11 | 0 | 31 |
| 12582675 | Methods for treatment of cancers harboring an H3K27M mutation | 🖼🧊📄§ | 2026-03-24 | 2042-07-26 | 0 | 31 |
| 12582598 | Topical anti-inflammatory pharmaceutical composition comprising Zileuton | 🖼🧊📄§ | 2026-03-24 | 2039-12-30 | 0 | 31 |
| 12582609 | Cancer vaccines | 🖼🧊📄§ | 2026-03-24 | 2036-10-21 | 0 | 31 |
| 12582616 | Molecular targets for modulation of dissociative and associative states | 🖼🧊📄§ | 2026-03-24 | 2041-08-09 | 0 | 31 |
| 12582624 | Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use | 🖼🧊📄§ | 2026-03-24 | 2041-04-21 | 0 | 31 |
| 12582622 | Sodium oxybate to treat idiopathic hypersomnia | 🖼🧊📄§ | 2026-03-24 | 2041-10-08 | 0 | 31 |
| 12582623 | Composition comprising EPA, MA and leucine for improving muscle function | 🖼🧊📄§ | 2026-03-24 | 2040-10-30 | 0 | 31 |
| 12582621 | Compositions and methods for delivering pharmaceutical agents | 🖼🧊📄§ | 2026-03-24 | 2041-06-11 | 0 | 31 |
| 12582625 | Methods for treating neuroblastoma | 🖼🧊📄§ | 2026-03-24 | 2044-12-23 | 0 | 31 |
| 12582627 | MCT formulations for improving cognitive functions | 🖼🧊📄§ | 2026-03-24 | 2041-05-17 | 0 | 31 |
| 12582628 | Methods for treating breast cancer | 🖼🧊📄§ | 2026-03-24 | 2042-04-13 | 0 | 31 |
| 12582633 | Methods of treating severe acute respiratory syndrome | 🖼🧊📄§ | 2026-03-24 | 2041-04-08 | 0 | 31 |
| 12582637 | Topical formulation for intradermal application and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2039-08-29 | 0 | 31 |
| 12582640 | Treatment of lower respiratory tract infection with tradipitant | 🖼🧊📄§ | 2026-03-24 | 2041-03-24 | 0 | 31 |
| 12582641 | Sulfur-containing compound based on glutarimide skeleton and application thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-25 | 0 | 31 |
| 12582642 | Composition for treating, improving, and/or preventing progression of bovine papillomatosis caused by bovine papillomavirus | 🖼🧊📄§ | 2026-03-24 | 2041-05-28 | 0 | 31 |
| 12582646 | Method for treating drug or alcohol dependency | 🖼🧊📄§ | 2026-03-24 | 2040-01-03 | 0 | 31 |
| 12582643 | Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy | 🖼🧊📄§ | 2026-03-24 | 2041-03-03 | 0 | 31 |
| 12582651 | Pharmaceutical composition comprising tadalafil or pharmaceutically acceptable salt thereof and dutasteride or pharmaceutically acceptable salt thereof exhibiting novel dissolution rate | 🖼🧊📄§ | 2026-03-24 | 2041-12-30 | 0 | 31 |
| 12582653 | Method for treating idiopathic pulmonary fibrosis | 🖼🧊📄§ | 2026-03-24 | 2040-06-24 | 0 | 31 |
| 12582655 | Methods of treating disorders using CSFIR inhibitors | 🖼🧊📄§ | 2026-03-24 | 2045-10-21 | 0 | 31 |
| 12582656 | Nucleotide analogues | 🖼🧊📄§ | 2026-03-24 | 2041-03-23 | 0 | 31 |
| 12582657 | Combination therapy including a KRAS G12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | 🖼🧊📄§ | 2026-03-24 | 2043-12-19 | 0 | 31 |
| 12582667 | Compositions and methods to treat metastatic gastrointestinal cancer | 🖼🧊📄§ | 2026-03-24 | 2040-09-25 | 0 | 31 |
| 12582668 | Methods for the treatment of alpha-1 antitrypsin deficiency (AATD) | 🖼🧊📄§ | 2026-03-24 | 2040-06-05 | 0 | 31 |
| 12582674 | Methods and treatment of trauma | 🖼🧊📄§ | 2026-03-24 | 2043-01-09 | 0 | 31 |
| 12584105 | Autologous cell replacement therapy for Parkinson's disease | 🖼🧊📄§ | 2026-03-24 | 2040-05-21 | 0 | 31 |
| 12582694 | Compounds and methods for inhibiting protozoan parasites | 🖼🧊📄§ | 2026-03-24 | 2042-05-12 | 0 | 31 |
| 12582599 | Methods for treatment of bladder cancer with gemcitabine | 🖼🧊📄§ | 2026-03-24 | 2042-07-07 | 0 | 31 |
| 12582706 | Tolerogenic antigen presenting cells | 🖼🧊📄§ | 2026-03-24 | 2040-12-11 | 0 | 31 |
| 12582705 | Composition comprising botulinum toxin or salt thereof for increasing endometrial blood flow rate | 🖼🧊📄§ | 2026-03-24 | 2040-04-28 | 0 | 31 |
| 12584149 | Nuclease-mediated genome editing of primary cells and related kits | 🖼🧊📄§ | 2026-03-24 | 2042-12-05 | 0 | 31 |